EOLS - エボラス (Evolus Inc.) エボラス

 EOLSのチャート


 EOLSの企業情報

symbol EOLS
会社名 Evolus Inc (エボラス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 エヴォルス(Evolus Inc.)は医療美容会社である。同社は医師および美容処置・治療法を提供することに重点を置く。また、自費の美容市場を提供することに焦点を当てる。製品候補であるPrabotulinumtoxinA(DWP-450)は大規模かつ成長的美容市場のニーズに対応する注入可能な900キロダルトンのボツリヌス毒素タイプである。同社は医師と患者にDWP-450による提案を提供する。OnabotulinumtoxinA(BOTOX)は米国にある神経毒素認可900kDaボツリヌス毒素A型複合体である。   エボラスは米国の医療審美企業。医師および患者に審美・美容手術や治療法での広範な選択肢を提供する。また、自己負担における医療市場に注力する。主な候補薬には、市場でニ―ズの高い900キロダルトン分子形態のA型ボツリヌス毒素注射剤「DWP-450」などがある。本社所在地はカリフォルニア州ア―バイン。   Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November, 2012 and is headquartered in Newport Beach, CA.
本社所在地 17901 Von Karman Avenue Suite 150 Irvine CA 92614 USA
代表者氏名 Vikram Malik ヴィクラム・マリク
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 949-284-4555
設立年月日 41214
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.evolus.com
nasdaq_url https://www.nasdaq.com/symbol/eols
adr_tso
EBITDA EBITDA(百万ドル) -18.51500
終値(lastsale) 16.43
時価総額(marketcap) 438270102.13
時価総額 時価総額(百万ドル) 438.27010
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 411.15510
当期純利益 当期純利益(百万ドル) -17.56000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Evolus Inc revenues was not reported. Net loss increased from $6.3M to $22.6M. Higher net loss reflects Revaluation of contingent royalty obliga increase from $0K to $9.1M (expense) General and Administrative - Balancing v increase from $1.8M to $6.8M (expense) Stock-based Compensation in SGA increase from $232K to $2.9M (expense).

 EOLSのテクニカル分析


 EOLSのニュース

   EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Evolus, Inc. Investors of Class Action and Lead Plaintiff Deadline: December 15, 2020  2020/10/20 15:00:00 PR Newswire
NEW YORK, Oct. 20, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Evolus, Inc. ("Evolus" or "the Company") (NASDAQ: EOLS) and certain of its officers, on behalf of shareholders who…
   The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout  2020/09/22 07:59:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21) …
   INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm  2020/09/09 18:36:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $EOLS #EOLS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc.
   Earnings Outlook For Evolus  2020/08/07 11:09:00 Benzinga
On Monday, August 10, Evolus (NASDAQ: EOLS) will release its latest earnings report. Benzinga's outlook for Evolus is included in the following …
   Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020  2020/07/27 20:01:00 GlobeNewswire
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach…
   The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout  2020/09/22 07:59:00 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21) …
   INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm  2020/09/09 18:36:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $EOLS #EOLS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc.
   Earnings Outlook For Evolus  2020/08/07 11:09:00 Benzinga
On Monday, August 10, Evolus (NASDAQ: EOLS) will release its latest earnings report. Benzinga's outlook for Evolus is included in the following …
   Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020  2020/07/27 20:01:00 GlobeNewswire
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach…
   The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs  2020/07/10 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
   Earnings Outlook For Evolus  2020/08/07 11:09:00 Benzinga
On Monday, August 10, Evolus (NASDAQ: EOLS) will release its latest earnings report. Benzinga's outlook for Evolus is included in the following …
   Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020  2020/07/27 20:01:00 GlobeNewswire
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach…
   The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs  2020/07/10 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …
   Lost Money in Evolus, Inc.?  2020/07/08 17:39:00 Business Wire
OAKLAND, Calif.--(BUSINESS WIRE)---- $EOLS #EOLS--Gibbs Law Group investigates legal claims on behalf of Evolus, Inc. investors.
   Evolus under pressure on potential barrier to Jeuveau sales in U.S. (NASDAQ:EOLS)  2020/07/07 10:36:16 Seeking Alpha
Evolus (NASDAQ:EOLS) slumps 38% premarket after the Administrative Law Judge (ALJ) overseeing the United States International Trade Commission (USITC) rele

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エボラス EOLS Evolus Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)